During a December press event hosted by the College of American Pathologists (CAP), Ben Bradley, MD, PhD, FCAP, medical director of virology at ARUP, suggested that the lab industry is much better prepared for H5N1 than it had been for COVID-19 and highlighted the CDC awards as well as the fact that labs have been able to leverage their existing flu testing businesses to prepare for H5N1 testing.
CAP President Donald S. Karcher, MD, FCAP, likewise, said that to his eyes, the FDA and CDC "are very much ahead of the curve on H5N1."
For the full article click here: Backed by CDC Funds, National Labs Launch Avian Flu Tests